The recent Rosen et al. study in NTRK fusion-positive cancers reported no co-occurrence with KRAS, NRAS, BRAF, EGFR, ALK, MET or ROS16, and we did not observe co-occurrence with these genes either. The gene discussed is EGFR; the disease is cancer.